Investor Presentaiton
For personal use only
Board of Directors
TELIX
PHARMACEUTICALS
Kevin McCann
Independent, Non-Executive Director and Chairman
Mr McCann has extensive Board experience with some of Australia's most
recognised companies. He is Chairman of China Matters, a former
Chairman of many companies including Macquarie Bank, a member of
Champions of Change, a Pro-Chancellor of the University of Sydney, and
a Trustee of the Sydney Opera House Trust.
Christian Behrenbruch
Group CEO and Managing Director
Dr Behrenbruch has over 20 years of healthcare entrepreneurship and
executive leadership experience. He has previously served in a CEO or
Executive Director capacity at Mirada Solutions, CTI Molecular Imaging, Fibron
Technologies and ImaginAb, Inc.
Oliver Buck
Non-Executive Director
Mr Buck is a bio-physicist who has spent his professional career in a variety of
entrepreneurial and management positions in industrial companies. Oliver has
served as founder and Managing Director of several companies in the fields of
manufacturing, technology, demilitarisation, pharmaceuticals and information
technologies.
Andreas Kluge
Non-Executive Director, Chief Medical Advisor
Dr Kluge has over 20 years of clinical research and development
experience, including as Founder, General Manager and Medical Director
for ABX-CRO, a full service CRO for Phase I-III biological,
radiopharmaceutical and anticancer trials based in Dresden, Germany.
Mark Nelson
Non-Executive Director
Dr Nelson is Chairman and Co-Founder of the Caledonia Investments
Group, and a Director of The Caledonia Foundation. He is Chairman of Art
Exhibitions Australia, a Director of Kaldor Public Art Projects, Director of
The Mindgardens Neuroscience Network, and serves as a Governor of the
Florey Neurosciences Institute.
Jann Skinner
Non-Executive Director
Ms Skinner has extensive experience in audit and accounting and in the
insurance industry. She was a partner of PricewaterhouseCoopers for 17
years before retiring in 2004. Jann is a Fellow of both Chartered Accountants
Australia & New Zealand and the Australian Institute of Company Directors.
Telix Pharmaceuticals Limited (ASX: TLX)
15View entire presentation